05-05-2025
This Week In AI Chips - RetinalGenix Gains Ground With New Laboratory Lease
Recent advancements in the biotechnology sector highlight a significant development with RetinalGenix Technologies, Inc. leasing a laboratory at the MBC BioLabs incubator in San Carlos, California. This strategic move is set to support the progress of RetinalGenix's innovative Pharmaco-Genetic Mapping platform, aimed at advancing therapies for neurodegenerative and retinal diseases. The facility offers access to cutting-edge scientific equipment and is conveniently located near resources critical for animal research studies. This collaboration also opens potential investment opportunities with Mission BioCapital, fostering further research and therapeutic development in ophthalmic and neurodegenerative fields.
Elsewhere in the market, was trading firmly up 10% and closing at CN¥170.47. Meanwhile, softened, down 2.2% to end trading at ¥28,420.
AMD's strategic moves in Data Center and AI, alongside the MI350 launch, offer a limited window to explore potential growth narratives. Discover how these opportunities might align with your investment strategy by clicking through to our detailed company narrative.
Also, revisit our 'Market Insights' article titled 'Investing In Innovation to Beat Stagflation,' where we highlighted the pivotal role of AI Chips in driving productivity growth amidst economic uncertainty—acting fast could capitalize on these dynamic shifts.
ended the day at $139.81 up 3.4%.
finished trading at $114.50 up 2.6%.
settled at $98.80 up 2.2%.
Investigate our full lineup of 49 AI Chip Stocks featuring SK hynix, ASML Holding and ASE Technology Holding right here.
Want Some Alternatives? We've found 18 US stocks that are forecast to pay a dividend yeild of over 6% next year. See the full list for free.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Sources:
Simply Wall St
"RetinalGenix Technologies, Inc. Announces Laboratory Lease Agreement with Life Science Incubator MBC BioLabs" from RetinalGeniX Technologies, Inc. on GlobeNewswire (published 05 May 2025)
Companies discussed in this article include SHSE:603893 NasdaqGS:QCOM NasdaqGS:NVDA NasdaqGS:AMD and TSE:6146.
This article was originally published by Simply Wall St.
Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
